阴道孕酮与宫颈环扎术在单胎妊娠、既往自发性早产及宫颈缩短妇女中预防早产的效果相当:更新的间接比较Meta分析
本更新间接比较Meta分析纳入5项阴道孕酮vs安慰剂试验(265例)和5项宫颈环扎术vs无环扎术试验(504例),以安慰剂/无环扎术为共同对照,比较两种干预在单胎妊娠、既往自发性早产及孕中期超声宫颈长度<25 mm妇女中预防早产及不良围产结局的疗效。调整间接比较未显示阴道孕酮与宫颈环扎术在降低早产或不良围产结局方面有统计学显著差异;两者效果相当,治疗选择取决于不良事件、成本效果及患者/医生偏好。
要点
- 阴道孕酮与宫颈环扎术在预防早产和改善围产结局方面效果相当。
- 调整间接比较未显示两种干预在降低早产或不良围产结局上有统计学显著差异。
- 治疗选择取决于不良事件、成本效果及患者/医生偏好。
核心结论
- 阴道孕酮与宫颈环扎术在单胎妊娠、既往自发性早产及孕中期超声宫颈缩短妇女中预防早产和改善围产结局方面效果相当。
- 治疗选择将取决于干预措施的不良事件和成本效果以及患者/医生的偏好。
研究设计与样本
- 更新的系统评价和调整间接比较Meta分析,以安慰剂/无环扎术为共同对照比较阴道孕酮与宫颈环扎术。
- 纳入5项阴道孕酮vs安慰剂随机对照试验(265例妇女)和5项宫颈环扎术vs无环扎术随机对照试验(504例妇女)。
- 检索MEDLINE、EMBASE、LILACS和CINAHL(从建库至2018年3月)、Cochrane数据库、参考文献目录和会议论文集。
- 纳入标准为在单胎妊娠、既往自发性早产及超声宫颈长度<25 mm妇女中比较阴道孕酮vs安慰剂/无治疗或宫颈环扎术vs无环扎术的随机对照试验。
- 主要结局为妊娠<35周早产和围产期死亡。
主要发现
- 与安慰剂相比,阴道孕酮显著降低妊娠<35周和<32周早产风险、复合围产期疾病/死亡、新生儿脓毒症、复合新生儿疾病及新生儿重症监护病房入住(RRs从0.29到0.68)。
- 与无环扎术相比,宫颈环扎术显著降低妊娠<37周、<35周、<32周和<28周早产风险、复合围产期疾病/死亡及出生体重<1500 g(RRs从0.64到0.70)。
- 调整间接比较Meta分析未显示阴道孕酮与宫颈环扎术在降低早产或不良围产结局方面有统计学显著差异。
临床怎么用
- 阴道孕酮与宫颈环扎术在单胎妊娠、既往自发性早产及孕中期超声宫颈缩短妇女中预防早产和改善围产结局方面效果相当。
- 治疗选择将取决于干预措施的不良事件和成本效果以及患者/医生的偏好。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An indirect comparison meta-analysis published in 2013 reported that both vaginal progesterone and cerclage are equally efficacious for preventing preterm birth and adverse perinatal outcomes in women with a singleton gestation, previous spontaneous preterm birth, and a sonographic short cervix. The efficacy of vaginal progesterone has been challenged after publication of the OPPTIMUM study. However, this has been resolved by an individual patient-data meta-analysis (Am J Obstet Gynecol. 2018;218:161-180). OBJECTIVE: To compare the efficacy of vaginal progesterone and cerclage in preventing preterm birth and adverse perinatal outcomes in women with a singleton gestation, previous spontaneous preterm birth, and a midtrimester sonographic short cervix. DATA SOURCES: MEDLINE, EMBASE, LILACS, and CINAHL (from their inception to March 2018); Cochrane databases, bibliographies, and conference proceedings. STUDY ELIGIBILITY CRITERIA: Randomized controlled trials comparing vaginal progesterone to placebo/no treatment or cerclage to no cerclage in women with a singleton gestation, previous spontaneous preterm birth, and a sonographic cervical length <25 mm. STUDY APPRAISAL AND SYNTHESIS METHODS: Updated systematic review and adjusted indirect comparison meta-analysis of vaginal progesterone vs cerclage using placebo/no cerclage as the common comparator. The primary outcomes were preterm birth <35 weeks of gestation and perinatal mortality. Pooled relative risks (RRs) with 95% confidence intervals were calculated. RESULTS: Five trials comparing vaginal progesterone vs placebo (265 women) and 5 comparing cerclage vs no cerclage (504 women) were included. Vaginal progesterone, compared to placebo, significantly reduced the risk of preterm birth <35 and <32 weeks of gestation, composite perinatal morbidity/mortality, neonatal sepsis, composite neonatal morbidity, and admission to the neonatal intensive care unit (RRs from 0.29 to 0.68). Cerclage, compared to no cerclage, significantly decreased the risk of preterm birth <37, <35, <32, and <28 weeks of gestation, composite perinatal morbidity/mortality, and birthweight <1500 g (RRs from 0.64 to 0.70). Adjusted indirect comparison meta-analyses did not show statistically significant differences between vaginal progesterone and cerclage in the reduction of preterm birth or adverse perinatal outcomes. CONCLUSION: Vaginal progesterone and cerclage are equally effective for preventing preterm birth and improving perinatal outcomes in women with a singleton gestation, previous spontaneous preterm birth, and a midtrimester sonographic short cervix. The choice of treatment will depend on adverse events and cost-effectiveness of interventions and patient/physician's preferences.
引用
- Conde-Agudelo A, Romero R, Da Fonseca E, et al. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Am J Obstet Gynecol. 2018. PMID: 29630885. doi:10.1016/j.ajog.2018.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。